Modifiable AHOs Are Prognostic in Testicular Cancer Survivors
Modifiable adverse health outcomes affect overall mortality and cancer mortality in testicular cancer survivors.
All articles by Jennifer Larson
Bone Marrow Infiltration a Risk Factor for Infusion-Related Reactions in B-Cell NHL
Bone marrow infiltration of lymphoma cells is a risk factor for grade 2 or higher infusion-related reactions in B-NHL treated with rituximab.
Pain-Related Guideline Implementation Often Insufficient in Outpatient Cancer Centers
Guideline implementation strategies did not provide a sufficient improvement in pain-related outcomes for patients with advanced cancer.
Adherence to Tamoxifen Therapy Declines in Male Patients With Breast Cancer
A population-based study revealed risk factors for endocrine therapy discontinuation and medication nonadherence in men with breast cancer.
Skin Cancer Risk Factors, Health Behaviors Differ Among Asian American Groups
Researchers identified cultural and practical differences among Asian American subgroups that should influence culturally aware counseling for these patients.
Potential of Bupropion for Loss of Sexual Desire in Female Cancer Survivors
Researchers sought to determine if bupriopion improved sexual desire, satisfaction, or fatigue interference with function in women cancer survivors.
5-Gene Risk Score Model Effectively Predicts Prognosis in Multiple Myeloma
Researchers sought to develop and validate a risk score model to predict prognosis for patients with multiple myeloma.
Excess Risk of CVD Low With Radiotherapy After Chemotherapy for Early-Stage Hodgkin Lymphoma
Researchers sought to determine the potential risk of cardiovascular mortality vs risk of disease recurrence in patients with early-stage HL receiving IFRT after ABVD.
Qualitative Study Sheds Light on Patient Trust in Shared Decision Making in MM Treatment
Researchers interviewed multiple myeloma patients to determine what factors influence their ability to participate in shared decision-making with their clinicians.
Algorithm Assesses Risk of Major Adverse Cardiovascular Events in TKI-Treated CML
Researchers sought to determine the accuracy of established tools in predicting the risk of cardiovascular events in patients with CML receiving TKIs.
- Loading...
Loading...
Next post in Hematologic Cancers
Loading... 
Loading...